EBS - Emergent Biosolutions Q3 Earnings Preview
Emergent Biosolutions (NYSE:EBS) is scheduled to announce Q3 earnings results on Thursday, November 5th, after market close.The consensus EPS Estimate is $2.15 (+77.7% Y/Y) and the consensus Revenue Estimate is $438.51M (+40.6% Y/Y).Over the last 2 years, EBS has beaten EPS estimates 75% of the time and has beaten revenue estimates 50% of the time.Over the last 3 months, EPS estimates have seen 2 upward revisions and 0 downward. Revenue estimates have seen 5 upward revisions and 1 downward.
For further details see:
Emergent Biosolutions Q3 Earnings Preview